The authors noted that, ‘For most adverse events, all levels of corticosteroid use exhibited significant risks of increased incidence compared to intermittent use.’
Euphoria associated with the stimulant methylphenidate may be mitigated by co-administration of naltrexone in patients with attention-deficit/hyperactivity disorder.
Clinicians may be overprescribing gabapentinoids, in part as a response to the opioid epidemic, and prescribing them for almost any type of pain.
Boehringer Ingelheim has initiated a clinical study to investigate the interchangeability between an adalimumab biosimilar candidate and Humira.
These findings highlight an urgent need to produce more evidence on the risks and benefits of off-label antidepressant use.
Peripheral anti-nociceptive effects of Substance P
Finding supports naloxone prescriptions for patients taking opioids for chronic pain
Pharmacogenetic testing yields information that informs how an individual will metabolize medications.
Many adults take five or more medications, often for preventable ills.
Naloxegol functions as a peripherally acting mu-opioid receptor antagonist in tissues such as the gastrointestinal tract, thereby decreasing the constipating effects of opioids.